B
Power Law company profile
Biosplice Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 2008 Decacorn
Global footprint
Where Biosplice Therapeutics has talent and traffic
Web traffic by country
3.4K
monthly visits
across markets
across markets
🇺🇸 United States100%
Patent intelligence
$171M patent portfolio · 71 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$171M
1.5% of valuation · 1.8× the top peer Silk Road Medical ($97M)
71 active patent families
Where Biosplice Therapeutics innovates
Blood vesselAngiogenesisOsteo arthritisNeurologic diseaseCartilage Diseases
Above peer median on Legal, Market
Quality vs same-sector peers
Biosplice Therapeutics on the five Patsnap quality dimensions
Biosplice Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Biosplice Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Biosplice Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Biosplice Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.